Furthermore, ubiquitin specific protease 22 (USP22), high levels of which are associated with EOC and poor prognosis, have been shown to regulate the cell cycle pathway downstream of TGFβ1, consequently stimulating ovarian cancer cell proliferation [48]. This evidence concerns the gene TGFB1 and ovarian carcinoma.